Are Nourianz and Osmolex the Same Thing?
Nourianz (istradefylline) and Osmolex ER are used to treat different aspects of Parkinson's disease.
Nourianz is indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease experiencing "off" episodes.
Osmolex ER is indicated for the treatment of drug-induced extrapyramidal reactions in adult patients with Parkinson's disease.
Nourianz and Osmolex ER belong to different drug classes. Nourianz is an adenosine receptor antagonist and Osmolex ER is an anti-Parkinson's agent.
Side effects of Nourianz and Osmolex ER that are similar include dizziness, constipation, nausea, hallucinations, and sleep problems (insomnia).
Side effects of Nourianz that are different from Osmolex ER include involuntary muscle movements.
Side effects of Osmolex ER that are different from Nourianz include lightheadedness, depression, anxiety and irritability, confusion, loss of appetite, dry mouth, loss of coordination, mottled purplish skin discoloration, swelling of extremities, dizziness on standing, headache, drowsiness, nervousness, strange dreams, agitation, dry nose, diarrhea, and fatigue.
Nourianz may interact with itraconazole, ketoconazole, clarithromycin, rifampin, St. John's wort, midazolam, atorvastatin, seizure medications, and digoxin.
Osmolex ER may interact with anticholinergic drugs, drugs affecting urinary pH (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), live influenza vaccines, and alcohol.
Withdrawal symptoms such as fever, confusion, severe muscle stiffness, psychosis, personality changes, agitation, aggressive behavior, hallucinations, paranoia, other psychotic or paranoia reactions may occur if you suddenly stop taking Osmolex ER.
What Are Possible Side Effects of Nourianz?
Common side effects of Nourianz include:
- involuntary muscle movements,
- hallucinations, and
What Are Possible Side Effects of Osmolex?
Common side effects of Osmolex include:
- anxiety and irritability,
- loss of appetite,
- dry mouth,
- loss of coordination,
- mottled purplish skin discoloration,
- swelling of extremities,
- dizziness on standing,
- strange dreams,
- dry nose,
- and fatigue
What Is Nourianz?
Nourianz (istradefylline) is an adenosine receptor antagonist indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease (PD) experiencing "off" episodes.
What Is Osmolex?
Osmolex ER (amantadine extended-release tablets) is indicated for the treatment of drug-induced extrapyramidal reactions in adult patients with Parkinson's disease.
What Drugs Interact With Nourianz?
Nourianz may interact with itraconazole, ketoconazole, clarithromycin, carbamazepine, rifampin, phenytoin, St. John's wort, midazolam, atorvastatin, and digoxin. Nourianz is not recommended for use during pregnancy; it may harm a fetus. Women of childbearing potential are advised to use contraception during treatment with Nourianz. It is unknown if Nourianz passes into breast milk or how it would affect a nursing infant. Consult your doctor before breastfeeding.
What Drugs Interact With Osmolex?
Osmolex ER may interact with anticholinergic drugs, drugs affecting urinary pH (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), live influenza vaccines, and alcohol. Tell your doctor all medications and supplements you use. Osmolex ER is not recommended for use during pregnancy; it may harm a fetus. Osmolex ER passes into breast milk but its effects on nursing infants is unknown. Consult your doctor before breastfeeding.
How Should Nourianz Be Taken?
The recommended dosage of Nourianz is 20 mg orally once daily. The dosage may be increased to a maximum of 40 mg once daily.
How Should Osmolex Be Taken?
The initial dosage of Osmolex ER is 129 mg orally once daily in the morning. The dosage may be increased in weekly intervals to a maximum daily dose of 322 mg once daily in the morning.
Health Solutions From Our Sponsors
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Vertical Pharmaceuticals, LLC. Osmolex ER Product Information.